Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 7, 2010, Pages 1199-1205

  Hayashi, Kyoko ^a   Narutaki, Kazuto ^b   Nagaoka, Yasuo ^b   Hayashi, Toshimitsu ^a   Uesato, Shinichi ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANSAI UNIVERSITY   (Japan)

Author keywords

Anti influenza A virus activity; Arctigenin; Arctiin; Immunocompromised mouse; Oseltamivir

Indexed keywords

ARCTIGENIN; ARCTIIN; FLUOROURACIL; OSELTAMIVIR; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARCTIUM; ARCTIUM LAPPA; ARTICLE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; IC 50; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A; LUNG LAVAGE; MONOTHERAPY; MOUSE; NONHUMAN; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; DOGS; FURANS; GLUCOSIDES; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS; LIGNANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED;

EID: 77954474480     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1199     Document Type: Article

References (23)

1. Okumura A., Kubota T., Kato T., Morishima T., Pediatr. Infect. Dis. J., 25, 572 (2006).
2. Izumi Y., Tokuda K., O'Dell K. A., Zorumski C. F., Narahashi T., Neurosci. Lett., 426, 54-58 (2007).
3. Yoshino T., Nisijima K., Shioda K., Kunio Y. K., Kato S., Neurosci. Lett., 438, 67-69 (2008).
4. Ichihara A., Oda K., Numata Y., Sakamura S., Tetrahedron Lett., 17, 3961-3964 (1976).
5. Ichihara A., Numata Y., Kanai S., Sakamura S., Agric. Biol. Chem., 41, 1813-1814 (1977).
6. Ichihara A., Kanai S., Nakamura Y., Sakamura S., Tetrahedron Lett., 19, 3035-3038 (1978).
7. Wang H. Y., Yang J. S., Acta Pharm. Sin., 28, 911-917 (1993).
8. Han B. H., Kang Y. H., Yang H. O., Park M. K., Phytochemistry, 37, 1161-1613 (1994).
9. Yang G., Xue D., Tingguo K., Changzhi Z., Zhi H., Xiaoyu Z., Zhongcaoyao, 33, 724-726 (2002).
10. Yang Z., Liu N., Huang B., Wang Y., Hu Y., Zhu Y., Zhong Yao Cai, 28, 1012-1014 (2005).
11. Yakhontova L. D., Kibal'chich P. N., Chem. Nat. Prod., 7, 287-288 (1971).
12. Hayashi K., Hayashi T., Ujita K., Takaishi Y., J. Antimicrob. Chemother., 37, 759-768 (1996).
13. Hoshino T., Hayashi T., Hayashi K., Hamada J., Lee J. B., Sankawa U., Biol. Pharm. Bull., 30, 1573-1575 (2007).
14. Kanekiyo K., Hayashi K., Takenaka H., Lee B. J., Hayashi T., Biol. Pharm. Bull., 21, 730-734 (1998).
15. Huang A. S., Wagner R. R., Proc. Soc. Exp. Biol. Med., 116, 863-869 (1964).
16. Elion G. B., Singer S., Hitchings G. H., J. Biol. Chem., 208, 477-488 (1954).
17. Andries K., Dewindt B., Snoeks J., Willebrords R., van Eemeren K., Stokbroekx R., Janssen P. A., Antimicrob. Agents Chemother., 36, 100-107 (1992).
18. Highlander S. L., Sutherland S. L., Gage P. J., Johnson D. C., Levine M., Glorioso J. C., J. Virol., 61, 3356-3364 (1987).
19. Martin K., Helenius A., J. Virol., 65, 232-244 (1991).
20. Clemons K. V., Gonzalez G. M., Singh G., Imai J., Espiritu M., Parmar R., Stevens D. A., Antimicrob. Agents Chemother., 50, 2650-2657 (2006).
21. Hofer M., Pospisil M., Vacek A., Hola J., Znojil V., Weiterova L., Streitova D., J. Pharmacol., 538, 163-167 (2006).
22. Michael G. I., Larisa V. G., Robert L. A., John T., Frederick G. H., J. Infect. Dis., 193, 760-764 (2006).
23. Monto A. S., McKimm-Breschkin J. L., Macken C., Hampson A. W., Hay A., Klimov A., Tashiro M., Webster R. G., Aymard K., Hayden F. G., Zambon M., Antimicrob. Agents Chemother., 50, 2395-2402 (2006).